Power Law company profile

Enveda Biosciences

Biotech & Life Sciences · Boulder, United States · Founded 2019 Unicorn

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$1–2.5B

Latest valuation · 2026

Unlock exact value

Headcount

100–500

Current team size

Unlock exact value

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Engineering new drugs from nature with knowledge graphs, metabolomics, and ML

Investors

26 investors on Enveda Biosciences's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 4 investors entered at this stage

Village Global

Wireframe Ventures

True Ventures

Chris Gibson

Series A 6 investors entered at this stage

Hummingbird Ventures

Lux Capital

Matthew De Silva

Lifeforce Capital

Two Sigma Ventures

Catalio Capital Management

Series B+ 16 investors entered at this stage

FPV Ventures

Dimension

Henry Kravis

Peakline Partners

Amino Collective

Lingotto Investment Management

The Nature Conservancy

Socium Ventures

IA Ventures

Level Ventures

Sanofi

JAZZ Venture Partners

Global footprint

Where Enveda Biosciences has talent and traffic

AI talent share

4.5% of workforce is AI talent
(17 of 376 staff)

Core AI102.66%

Other AI71.86%

Non-AI workforce35995.48%

Workforce by country

8 countries with
team presence

🇺🇸 United States50.6%

🇮🇳 India43.6%

🇨🇦 Canada2.8%

🇩🇪 Germany0.8%

🇬🇧 United Kingdom0.6%

Top 5 of 8 shown

Web traffic by country

26K monthly visits
across markets

🇺🇸 United States75.8%

🇮🇳 India14.2%

🇬🇧 United Kingdom5%

🇪🇸 Spain4.2%

🇨🇿 Czech Republic0.8%

Top 5 markets shown

Patent intelligence

$141k patent portfolio · 8 active families

Estimated portfolio value

$141k

0.01% of valuation · 2326.1× smaller than top peer Genmab ($328M)

8 active patent families

Where Enveda Biosciences innovates Mass Spectrometry-Mass SpectrometryMolecular biologyPharmacologyDiseasePerylene derivatives

Where Enveda Biosciences concentrates vs peers

Each axis is a top-10 topic across Enveda Biosciences and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Sentiment on X

What X is saying about Enveda Biosciences

An AI-synthesized read of the highest-engagement posts about Enveda Biosciences on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Enveda Biosciences on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles